Published in Clin Exp Immunol on November 01, 2006
Immune activation and collateral damage in AIDS pathogenesis. Front Immunol (2013) 1.08
Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation. Blood (2012) 1.07
Altered thymic function during interferon therapy in HCV-infected patients. PLoS One (2012) 0.82
Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis. J Clin Immunol (2011) 0.80
Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy? Clin Exp Immunol (2010) 0.75
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature (1999) 34.47
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science (1997) 15.09
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med (2004) 9.72
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA (2001) 7.63
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA (2002) 5.56
Side effects of therapy of hepatitis C and their management. Hepatology (2002) 5.18
Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med (2000) 4.54
11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med (2001) 3.94
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA (2004) 3.74
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med (2000) 3.70
HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity (2004) 2.86
Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J Clin Invest (1997) 2.69
Hepatitis C in the HIV-Infected Person. Ann Intern Med (2003) 2.67
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med (2000) 2.49
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS (2004) 2.39
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med (1999) 2.33
Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol (2001) 1.97
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patients. AIDS (2000) 1.97
Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis (2003) 1.93
Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin Infect Dis (2006) 1.87
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection. Hepatology (2002) 1.81
p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev (1999) 1.68
Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infection. Lancet (1993) 1.55
Impairment of T and B cell development by treatment with a type I interferon. J Exp Med (1998) 1.54
T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood (2002) 1.39
Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha. Gastroenterology (2002) 1.14
De novo T-cell generation in patients at different ages and stages of HIV-1 disease. Blood (2004) 1.07
Dynamics of T cells and TCR excision circles differ after treatment of acute and chronic HIV infection. J Immunol (2002) 0.99
Reevaluation of T cell receptor excision circles as a measure of human recent thymic emigrants. J Immunol (2002) 0.99
Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C. Drugs (2002) 0.95
Drug-induced lymphopenia: focus on CD4+ and CD8+ cells. Drug Saf (1999) 0.86
Combination treatment for chronic hepatitis C: what is the role of ribavirin? Fundam Clin Pharmacol (2001) 0.85
Postthymic differentiation of CD4 T lymphocytes: naive versus memory subsets and further specialization among memory cells. Chem Immunol (1992) 0.83
Efficacy and safety of pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. AIDS Res Hum Retroviruses (2006) 0.82
Opportunistic infections and CD4 lymphocytopenia with interferon treatment in HIV-1 infected patients. Lancet (1993) 0.81
Efficacy and safety of alpha-interferon treatment for chronic hepatitis C in HIV-infected patients. HIV-Hepatitis Spanish Study Group. J Infect (1995) 0.80
Influence of interferon-alpha on cytokine expression by the bone marrow microenvironment--impact on treatment of myeloproliferative disorders. Leuk Lymphoma (1996) 0.80
CD4+ T-lymphocytopenia in HIV-infected patients receiving interferon therapy for chronic hepatitis C. HIV-Hepatitis Spanish Study Group. AIDS (1994) 0.80
CD4+ lymphocytopenia in systemic lupus erythematosus. Ann Intern Med (1994) 0.79
Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon. Clin Microbiol Infect (2004) 0.78
Possible mechanism of toxicity of zidovudine by induction of apoptosis of CD4+ and CD8+ T-cells in vivo. Eur J Clin Microbiol Infect Dis (2001) 0.77
Controlling mature CD4+ T cell responses. Immunol Res (2000) 0.76
Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000. HIV Clin Trials (2002) 0.76
Interactions of aromatic residues of proteins with nucleic acids. Fluorescence studies of the binding of oligopeptides containing tryptophan and tyrosine residues to polynucleotides. Biochemistry (1975) 1.66
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy. Int J STD AIDS (2007) 1.48
Hepatocyte growth factor and chronic hepatitis C. Rev Esp Enferm Dig (2010) 1.45
Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients. Gut (2009) 1.43
Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation. Am J Surg Pathol (2001) 1.39
Detection of gamma rays from a starburst galaxy. Science (2009) 1.38
Novel defect structures in nematic liquid crystal shells. Phys Rev Lett (2007) 1.31
High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin Infect Dis (2000) 1.30
Compliance with triage to intensive care recommendations. Crit Care Med (2001) 1.28
Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut (2005) 1.28
Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med (2006) 1.22
Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients. HIV Med (2006) 1.16
Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin. J Viral Hepat (2006) 1.12
Isolation of gram-positive rods that resemble but are clearly distinct from Actinomyces pyogenes from mixed wound infections. J Clin Microbiol (1993) 1.12
Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort. J Infect (2010) 1.11
Binding of tryptamine and 5-hydroxytryptamine (serotonin) to nucleic acids. Fluorescence and proton magnetic resonance studies. Biochemistry (1971) 1.11
Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus (2002) 1.07
Influence of gender on social outcome in schizophrenia. Acta Psychiatr Scand (2002) 1.06
Viral infections of the central nervous system in Spain: a prospective study. J Med Virol (2012) 1.04
Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination. J Med Virol (2004) 1.02
Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis (1997) 1.02
Splenic abscesses in typhoid fever: US and CT studies. J Comput Assist Tomogr (1993) 1.02
Efficacy of directly observed treatment of HIV infection: experience in AIDS welfare homes. Eur J Clin Microbiol Infect Dis (2004) 1.01
Gender differences and outcome in schizophrenia: a 2-year follow-up study in a large community sample. Eur Psychiatry (2003) 0.99
Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists. Clin Pharmacol Ther (1999) 0.99
[Clinical characteristics of Cuban epidemic neuropathy]. Rev Neurol (1997) 0.99
Cross-cultural study comparing the association of familism with burden and depressive symptoms in two samples of Hispanic dementia caregivers. Aging Ment Health (2006) 0.97
Purification, characterization and immobilization of proteinase inhibitors from Stichodactyla helianthus. Toxicon (1997) 0.96
Adhesion molecules as a prognostic marker of liver cirrhosis. Scand J Gastroenterol (2005) 0.95
An experimental study of the electrospraying of water in air at atmospheric pressure. J Am Soc Mass Spectrom (2004) 0.95
Topological changes in bipolar nematic droplets under flow. Phys Rev Lett (2007) 0.95
Epidemic asthma in Cartagena, Spain, and its association with soybean sensitivity. Epidemiology (1993) 0.94
Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci (2001) 0.93
Unusual malignant tumours in patients with HIV infection. Int J STD AIDS (2002) 0.93
Sertaconazole in the treatment of mycoses: from dermatology to gynecology. Int J Gynaecol Obstet (2000) 0.92
Gender differences in a sample of schizophrenic outpatients. Compr Psychiatry (2001) 0.91
Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis. Clin Exp Immunol (2009) 0.91
Fluorescence study of interactions between valyl- t RNA synthetase and valine-specific tRNA's from Escherichia coli. Biochem Biophys Res Commun (1969) 0.90
Contribution of extracellular Glu residues to the structure and function of bacteriorhodopsin. Presence of specific cation-binding sites. J Biol Chem (2001) 0.90
Differential clinical features of early-onset panic disorder. J Affect Disord (1999) 0.89
Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines. Scand J Rheumatol (2009) 0.88
Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients. AIDS (1998) 0.88
Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis. J Leukoc Biol (2007) 0.88
Fluorescence studies of interactions between Escherichia coli valyl-tRNA synthetase and its substrates. J Mol Biol (1971) 0.87
Simple and double emulsions via coaxial jet electrosprays. Phys Rev Lett (2007) 0.87
Immunohistochemical characterisation of classical scrapie neuropathology in sheep. J Comp Pathol (2009) 0.87
Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Eur J Clin Microbiol Infect Dis (1996) 0.87
[Gastric cavernous hemangioma as a cause of upper digestive hemorrhage]. Rev Esp Enferm Dig (1995) 0.87
Photoaffinity labelling with the cytokinin agonist azido-CPPU of a 34 kDa peptide of the intracellular pathogenesis-related protein family in the moss Physcomitrella patens. Plant Mol Biol (2001) 0.86
Atherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Nétar Study). Int J STD AIDS (2005) 0.86
Immunohistochemical approach to the pathogenesis of bovine spongiform encephalopathy in its early stages. J Virol Methods (2006) 0.85
Monozygotic twins with Alzheimer's disease treated with melatonin: Case report. J Pineal Res (1998) 0.84
Effect of melatonin in selected populations of sleep-disturbed patients. Biol Signals Recept (1999) 0.84
Parenchymal and vascular lesions in ageing equine brains: histological and immunohistochemical studies. J Comp Pathol (2009) 0.84
Search for a dark matter annihilation signal from the galactic center halo with H.E.S.S. Phys Rev Lett (2011) 0.84
Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting. HIV Med (2014) 0.83
Ventricular mass and diastolic function in patients infected by the human immunodeficiency virus. Heart (2000) 0.82
[Psychotropic medications use in Spain. Results of the ESEMeD-Spain study]. Actas Esp Psiquiatr (2007) 0.82
Depersonalization in panic disorder: a clinical study. Compr Psychiatry (2000) 0.82
Detection of hepatitis G virus (HGV) RNA and antibodies to the HGV envelope protein E2 in a cohort of hemodialysis patients. J Clin Microbiol (2000) 0.82
Characterization of worry according to severity of anxiety in elderly living in the community. Aging Ment Health (2003) 0.82
Relationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypes. Liver (1999) 0.82
Molecular profiling and comparison of field transmissible spongiform encephalopathy cases diagnosed in Catalunya. Vet J (2006) 0.82
Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 study. J Acquir Immune Defic Syndr (2001) 0.82
Effect of patient adherence to antiretroviral therapy on CD4+ cell count, HIV-1 RNA, and serum concentrations of tumor necrosis factor and its soluble receptors. Eur J Clin Microbiol Infect Dis (2000) 0.81
Effect of the menstrual cycle in ethanol pharmacokinetics. J Appl Toxicol (1998) 0.81
[46 XY gonadal dysgenesis and dysgerminoma (author's transl)]. Reproduccion (1981) 0.81
Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy. Eur J Clin Microbiol Infect Dis (2012) 0.81
The endometrial biopsy for diagnosis of luteal phase deficiency. Fertil Steril (1985) 0.80
Model of an asymmetric DPPC/DPPS membrane: effect of asymmetry on the lipid properties. A molecular dynamics simulation study. J Phys Chem B (2006) 0.80
Influence of CD4+ status on the invasiveness of pneumococcal pneumonia in HIV patients. Eur J Clin Microbiol Infect Dis (1996) 0.80
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial. Eur J Clin Microbiol Infect Dis (2010) 0.80
Pharmacokinetics and tolerance of sertaconazole in man after repeated percutaneous administration. Arzneimittelforschung (1992) 0.80
Usefulness of sputum culture for diagnosis of bacterial pneumonia in HIV-infected patients. Eur J Clin Microbiol Infect Dis (2002) 0.80
Impact of Acute Hepatitis A Virus (HAV) Infection on HIV Viral Load in HIV-Infected Patients and Influence of HIV Infection on Acute HAV Infection. J Int Assoc Physicians AIDS Care (Chic) (2011) 0.80
Immunopathogenic aspects of infection by the human immunodeficiency virus in Venezuela. Bull Pan Am Health Organ (1989) 0.80
[Bacteremia and recurrent arthritis caused by Streptococcus pyogenes in a heroin addict with AIDS]. Enferm Infecc Microbiol Clin (1994) 0.79
Comparative study of the PrPBSE distribution in brains from BSE field cases using rapid tests. J Virol Methods (2005) 0.79
Metastatic ovarian strumosis in an in-vitro fertilization patient. Hum Reprod (1993) 0.79
Once-daily antiretroviral therapy: Spanish Consensus Statement. J Antimicrob Chemother (2005) 0.79
Steady cone-jet electrosprays in liquid insulator baths. J Colloid Interface Sci (2004) 0.79
Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases. Clin Transl Oncol (2008) 0.79
[Antifungal susceptibility of clinical isolates of Scopulariopsis species]. Rev Esp Quimioter (2014) 0.78
The significance of luteal phase deficiency on fertility: a diagnostic and therapeutic approach. Hum Reprod (1986) 0.78
Endometrial biopsy inadvertently taken in the cycle of conception. Int J Gynaecol Obstet (1984) 0.78
Towards breast tomography with synchrotron radiation at Elettra: first images. Phys Med Biol (2016) 0.78
Interaction of disulfide groups with nucleic acid bases. Photochem Photobiol (1976) 0.78
Pleural effusion in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (1997) 0.78
Amoxicillin kinetics and ethanol ingestion. Int J Clin Pharmacol Ther Toxicol (1988) 0.78
Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon and ribavirin: differences between pegylated and standard interferon. Clin Microbiol Infect (2004) 0.78